A micropeptide named AF127577.4-ORF, encoded by its namesake lncRNA, has been shown to diminish glioblastoma cell proliferation through its regulation of METTL3 and the ERK pathway, which could be a promising approach to glioblastoma management [50]. Here, METTL3 is linked to glioblastoma.